Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris
Clinical trial NCT02613910 · TERMINATED
Trial details
- NCT number
- NCT02613910
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-23
- Primary completion
- 2016-03-23
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.